Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Clinical Outcomes in Piriformis Syndrome

April 5, 2023 updated by: Ayesha Jamil, University of Lahore

Comparative Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Pain, Functional Disability and Sleep Quality in Piriformis Syndrome

The aim of this study is to compare the effects of hold relax agonist contraction and active release therapy on reducing pain intensity, improving functioning and sleep quality in patient with piriformis syndrome.

Both these techniques are passive, non-invasive manual therapy techniques which are easy to perform and less time consuming and may yield better outcomes resulting improved quality of life.

Study Overview

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • The University of Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age group 25-55 years
  2. Both male and female.
  3. Gluteal pain with or without radicular symptoms.
  4. Patients of piriformis syndrome diagnosed by orthopedic consultant.
  5. Sub-acute and chronic piriformis syndrome.
  6. Unilateral pain.
  7. Pain score equal to and greater than 3 according to pain rating scale.

Exclusion Criteria:

  1. Intermittent vascular claudication and spondylolisthesis.
  2. Past history of hip, femur or vertebral fracture
  3. Past history of spinal surgery.
  4. Spinal tuberculosis.
  5. Rheumatoid disease.
  6. Disc pathology, sacroiliac joint dysfunction or mechanical back pain.
  7. History of infectious disease.
  8. Leg length discrepancy.
  9. Any postural abnormality or deformity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
This group of participants will receive Hold Relax with Agonist Contraction (HR-AC) technique with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.
  1. Participant will be in prone lying and heating pad will be applied on gluteal region for 10 to 15 minutes.
  2. Passive sustained stretch to piriformis will be applied for 10 seconds.
  3. The participant will be asked to actively contract the muscle for about 10 seconds (isometric contraction) and then relax.
  4. Immediately after that participant is ask to again actively contract the muscle against therapist resistance for 6-10 seconds.
  5. Ask the participant to relax while therapist will apply stretch the muscle to its new tissue tension barrier position and this position will be maintained for 30 seconds.
  6. This maneuver is repeated for 3 to 4 repetitions, each starting from where the previous finished.
Other Names:
  • Proprioceptive Neuromuscular Facilitation Technique
Active Comparator: Group B
This group of participants will receive Active Release Therapy, a kind of soft tissue mobilization along with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.
  1. Specific muscle will be warmed up by applying heating pad for 10 to 15 minutes.
  2. Patient will be positioned prone lying and the therapist will be standing at the side of affected limb.
  3. Therapist will apply deep pressure at the area of tenderness while patient will actively move the limb from internal to external rotation repeatedly.
  4. This maneuver will take about 15 minutes to complete in one session and will be applied alternatively 3 days a week for two weeks.
  5. After this, cold pack is applied and general ROMs and strengthening exercises are performed to prevent soreness
Other Names:
  • Soft Tissue Mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Intensity
Time Frame: Pain score will be measured at the baseline, at end of first session and at 6th session on 2nd week
Numeric Pain Rating Scale will be used to measure the intensity of pain
Pain score will be measured at the baseline, at end of first session and at 6th session on 2nd week
Change in Functional Disability
Time Frame: Change in functional status will be measured at the baseline, at end of first session and at end of 6th session
Ronald-Morris Disability Questionnaire will be used to a assess the level of disability
Change in functional status will be measured at the baseline, at end of first session and at end of 6th session
Sleep Quality
Time Frame: Sleep quality will be measured at the baseline, at end of first session and at end of 6th session
Chronic Pain Sleep Inventory will be used to to assess the quality of sleep on a 100 mm VAS scale
Sleep quality will be measured at the baseline, at end of first session and at end of 6th session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ayesha Jamil, M.Phil, The University of Lahore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2022

Primary Completion (Actual)

November 22, 2022

Study Completion (Actual)

November 22, 2022

Study Registration Dates

First Submitted

May 6, 2022

First Submitted That Met QC Criteria

May 6, 2022

First Posted (Actual)

May 11, 2022

Study Record Updates

Last Update Posted (Actual)

April 6, 2023

Last Update Submitted That Met QC Criteria

April 5, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlies the results reported in article after deidentification

IPD Sharing Time Frame

Immediately following publication. Ending in 36 months.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Piriformis Syndrome

Clinical Trials on Hold Relax with Agonist Contraction

3
Subscribe